Placebo (for Dronedarone)

DRUG4 trials

Sponsors

Sanofi

Conditions

Atrial Fibrillation

Phase 3

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

TerminatedNCT01151137

SanofiAtrial Fibrillation

Start: 2010-07-31End: 2011-09-30Updated: 2012-10-26

Phase 4

Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)

TerminatedNCT01026090

SanofiAtrial Fibrillation

Start: 2009-11-30End: 2011-12-31Updated: 2014-08-06

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

TerminatedNCT01135017

SanofiAtrial Fibrillation

Start: 2010-07-31End: 2012-02-29Updated: 2013-04-11

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

TerminatedNCT01198873

SanofiAtrial Fibrillation

Start: 2010-09-30End: 2012-01-31Updated: 2013-02-12

Related Papers

Interaction Between Digoxin and Dronedarone in the PALLAS Trial

Circulation Arrhythmia and Electrophysiology2014-11-0775 citations

Dronedarone in high-risk permanent atrial fibrillation.

2011-11-14382 citations